Lantern Pharma Inc. logo

LTRNLantern Pharma Inc.

LTRN Stock Price, Valuation & Chart | Lantern Pharma Inc.

Compare

LTRN Historical price chart

LTRN Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization24.63M
PE Ratio-1.19
EPS-1.62
Trading Volume162.61K
Today's High/Low2.07/1.9
Dividend Yield0.00
52 Week High/Low4.7/1.11
Shares Outstanding12.76M
LTRN Financial Statement
LTRN Analyst ratings
LTRN Analysis & performance metrics

LTRN Company profile

Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development…

LTRN Management team

Management
David R. MargraveCFO
Chief Financial Officer & Secretary
Panna SharmaCEO
President, Chief Executive Officer & Director
Marc C. Chamberlain M.D.
Chief Medical Officer of Starlight Therapeutics
Kishor Gopaldas Bhatia Ph.D.
Chief Scientific Officer & Scientific Consultant
Peter L. Nara D.V.M., M.S., Ph.D.
Co-Founder & Advisor
Ernest Kitt B.S., M.S
Head of Clinical Operations
Total 6 executives

LTRN Frequently asked questions

What is Lantern Pharma Inc. (LTRN) Stock Price?

Current stock price of Lantern Pharma Inc. (LTRN) stock is $1.930. The stock price is -4.46% lower in the session. The intraday range can be seen from this page. Volume of Lantern Pharma Inc. (LTRN) stock is 162.61K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Lantern Pharma Inc. (LTRN) stock price going up or down today?

The stock price of Lantern Pharma Inc. (LTRN) can change with earnings, company news, and overall market sentiment. Lantern Pharma Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Lantern Pharma Inc. stock expensive at its current price?

Whether Lantern Pharma Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for LTRN on this page is -1.19. EPS on this page is -1.62. Compare those figures with peers and growth expectations before deciding if the current Lantern Pharma Inc. price is justified.

How has the stock price of Lantern Pharma Inc. (LTRN) performed historically?

Historical performance for Lantern Pharma Inc. (LTRN) is shown on the price chart on this page. Review multi-period moves alongside volume to see how LTRN reacted to past earnings and market events.

Should I buy Lantern Pharma Inc. (LTRN) stock, at this price?

Buying Lantern Pharma Inc. (LTRN) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.